Annex
United Kingdom
Rejected health claims
| Application – Relevant provisions of Regulation (EC) No 1924/2006 | Nutrient, substance, food or food category | Claim | EFSA opinion reference |
|---|---|---|---|
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | ‘Hypo-caloric snacks (KOT products)’ | Contributes to reduce the adipocytes size at the abdominal level, in the context of a low-calorie diet | Q-2011-00016 |
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) | Peptides IPP and VPP help to maintain normal blood pressure | Q-2011-00121 |
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Appl’In® polyphenolic apple extract powder (Malus domestica) | Appl’In® contributes to decrease glycaemic response in women | Q-2011-00190 |
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Coffee C21 | Regular consumption of Coffee C21 contributes to the maintenance of DNA integrity in cells of the body | Q-2011-00783 |
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Diacylglycerol (DAG) oil | Substituting your usual vegetable oil with DAG oil helps in the management of body weight through weight loss | Q-2011-00751 |
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Spermidine | Spermidine prolongs the growing phase (anagen) of the hair cycle | Q-2011-00896 |
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Bimuno® (Bimuno® GOS) | Regular daily consumption of 1,37 g galacto-oligosaccharides from Bimuno® may reduce intestinal discomfort | Q-2011-00401 |
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Sugar beet fibre | Sugar beet fibre decreases intestinal transit time | Q-2011-00971 |